Seagen Inc. Insider Trading for August 2016
FREE EMAIL WATCHDOG
Get free email notifications about insider trading in Seagen Inc..
- Your email is safe with us.
- The service is free and you can unsubscribe at any time.
General | Insiders | Insider Transactions | Monthly Overview | Weekly Overview
Overview of insider trading in Seagen Inc. for August 2016.
| Date | Ticker | Company | Owner | Relationship | Transaction | Code | Cost ($) | Shares | Transaction Value ($) | Total Shares | % Holdings |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Aug 30 2016 | SGEN | SEATTLE GENETICS I ... | SIMPSON TODD E | Chief Financial Off ... | Option Exercise | A | 45.30 | 42,793 | 1,938,523 | 42,793 | |
| Aug 30 2016 | SGEN | SEATTLE GENETICS I ... | SIMPSON TODD E | Chief Financial Off ... | Option Exercise | A | 45.30 | 2,207 | 99,977 | 2,207 | |
| Aug 30 2016 | SGEN | SEATTLE GENETICS I ... | SIMPSON TODD E | Chief Financial Off ... | Grant | A | 0.00 | 18,000 | 0 | 209,445 | 191.4 K to 209.4 K (+9.40 %) |
| Aug 30 2016 | SGEN | SEATTLE GENETICS I ... | SIEGALL CLAY B | President and CEO | Option Exercise | A | 45.30 | 177,793 | 8,054,023 | 177,793 | |
| Aug 30 2016 | SGEN | SEATTLE GENETICS I ... | SIEGALL CLAY B | President and CEO | Option Exercise | A | 45.30 | 2,207 | 99,977 | 2,207 | |
| Aug 30 2016 | SGEN | SEATTLE GENETICS I ... | SIEGALL CLAY B | President and CEO | Grant | A | 0.00 | 72,000 | 0 | 604,734 | 532.7 K to 604.7 K (+13.52 %) |
| Aug 30 2016 | SGEN | SEATTLE GENETICS I ... | LIU JEAN I | GC/EVP, Leg Affairs | Option Exercise | A | 45.30 | 35,293 | 1,598,773 | 35,293 | |
| Aug 30 2016 | SGEN | SEATTLE GENETICS I ... | LIU JEAN I | GC/EVP, Leg Affairs | Option Exercise | A | 45.30 | 2,207 | 99,977 | 2,207 | |
| Aug 30 2016 | SGEN | SEATTLE GENETICS I ... | LIU JEAN I | GC/EVP, Leg Affairs | Grant | A | 0.00 | 15,000 | 0 | 51,400 | 36.4 K to 51.4 K (+41.21 %) |
| Aug 30 2016 | SGEN | SEATTLE GENETICS I ... | HIMES VAUGHN B | EVP, Proc Svcs & Te ... | Option Exercise | A | 45.30 | 40,293 | 1,825,273 | 40,293 | |
| Aug 30 2016 | SGEN | SEATTLE GENETICS I ... | HIMES VAUGHN B | EVP, Proc Svcs & Te ... | Option Exercise | A | 45.30 | 2,207 | 99,977 | 2,207 | |
| Aug 30 2016 | SGEN | SEATTLE GENETICS I ... | HIMES VAUGHN B | EVP, Proc Svcs & Te ... | Grant | A | 0.00 | 17,000 | 0 | 125,779 | 108.8 K to 125.8 K (+15.63 %) |
| Aug 30 2016 | SGEN | SEATTLE GENETICS I ... | DRACHMAN JONATHAN G | CMO & EVP, R & D | Option Exercise | A | 45.30 | 70,293 | 3,184,273 | 70,293 | |
| Aug 30 2016 | SGEN | SEATTLE GENETICS I ... | DRACHMAN JONATHAN G | CMO & EVP, R & D | Option Exercise | A | 45.30 | 2,207 | 99,977 | 2,207 | |
| Aug 30 2016 | SGEN | SEATTLE GENETICS I ... | DRACHMAN JONATHAN G | CMO & EVP, R & D | Grant | A | 0.00 | 29,000 | 0 | 113,255 | 84.3 K to 113.3 K (+34.42 %) |
| Aug 30 2016 | SGEN | SEATTLE GENETICS I ... | DOBMEIER ERIC | Chief Operating Off ... | Option Exercise | A | 45.30 | 70,293 | 3,184,273 | 70,293 | |
| Aug 30 2016 | SGEN | SEATTLE GENETICS I ... | DOBMEIER ERIC | Chief Operating Off ... | Option Exercise | A | 45.30 | 2,207 | 99,977 | 2,207 | |
| Aug 30 2016 | SGEN | SEATTLE GENETICS I ... | DOBMEIER ERIC | Chief Operating Off ... | Grant | A | 0.00 | 29,000 | 0 | 87,767 | 58.8 K to 87.8 K (+49.35 %) |
| Aug 30 2016 | SGEN | SEATTLE GENETICS I ... | Cline Darren S | EVP, Commercial | Option Exercise | A | 45.30 | 37,793 | 1,712,023 | 37,793 | |
| Aug 30 2016 | SGEN | SEATTLE GENETICS I ... | Cline Darren S | EVP, Commercial | Option Exercise | A | 45.30 | 2,207 | 99,977 | 2,207 | |
| Aug 30 2016 | SGEN | SEATTLE GENETICS I ... | Cline Darren S | EVP, Commercial | Grant | A | 0.00 | 16,000 | 0 | 56,973 | 41 K to 57 K (+39.05 %) |
| Aug 24 2016 | SGEN | SEATTLE GENETICS I ... | DOBMEIER ERIC | Chief Operating Off ... | Option Exercise | M | 26.10 | 3,831 | 99,989 | 0 | |
| Aug 24 2016 | SGEN | SEATTLE GENETICS I ... | DOBMEIER ERIC | Chief Operating Off ... | Sell | S | 48.00 | 12,589 | 604,272 | 58,767 | 71.4 K to 58.8 K (-17.64 %) |
| Aug 24 2016 | SGEN | SEATTLE GENETICS I ... | DOBMEIER ERIC | Chief Operating Off ... | Buy | M | 26.10 | 3,831 | 99,989 | 71,356 | 67.5 K to 71.4 K (+5.67 %) |
| Aug 22 2016 | SGEN | SEATTLE GENETICS I ... | Cline Darren S | EVP, Commercial | Sell | S | 46.59 | 1,774 | 82,652 | 40,973 | 42.7 K to 41 K (-4.15 %) |
| Aug 22 2016 | SGEN | SEATTLE GENETICS I ... | DOBMEIER ERIC | Chief Operating Off ... | Sell | S | 46.59 | 5,411 | 252,102 | 67,525 | 72.9 K to 67.5 K (-7.42 %) |
| Aug 22 2016 | SGEN | SEATTLE GENETICS I ... | DRACHMAN JONATHAN G | CMO & EVP, R & D | Sell | S | 46.59 | 3,991 | 185,943 | 84,255 | 88.2 K to 84.3 K (-4.52 %) |
| Aug 22 2016 | SGEN | SEATTLE GENETICS I ... | HIMES VAUGHN B | EVP, Proc Svcs & Te ... | Sell | S | 46.59 | 3,991 | 185,943 | 108,779 | 112.8 K to 108.8 K (-3.54 %) |
| Aug 22 2016 | SGEN | SEATTLE GENETICS I ... | SIEGALL CLAY B | President and CEO | Sell | S | 46.59 | 23,381 | 1,089,337 | 532,734 | 556.1 K to 532.7 K (-4.20 %) |
| Aug 22 2016 | SGEN | SEATTLE GENETICS I ... | SIMPSON TODD E | Chief Financial Off ... | Sell | S | 46.59 | 3,991 | 185,943 | 191,445 | 195.4 K to 191.4 K (-2.04 %) |
| Aug 22 2016 | SGEN | SEATTLE GENETICS I ... | DOBMEIER ERIC | Chief Operating Off ... | Option Exercise | A | 39.15 | 44,946 | 1,759,636 | 44,946 | |
| Aug 22 2016 | SGEN | SEATTLE GENETICS I ... | DOBMEIER ERIC | Chief Operating Off ... | Option Exercise | A | 39.15 | 2,554 | 99,989 | 2,554 | |
| Aug 22 2016 | SGEN | SEATTLE GENETICS I ... | DOBMEIER ERIC | Chief Operating Off ... | Option Exercise | M | 20.52 | 4,688 | 96,198 | 0 | |
| Aug 22 2016 | SGEN | SEATTLE GENETICS I ... | DOBMEIER ERIC | Chief Operating Off ... | Option Exercise | M | 15.46 | 245 | 3,788 | 0 | |
| Aug 22 2016 | SGEN | SEATTLE GENETICS I ... | DOBMEIER ERIC | Chief Operating Off ... | Grant | A | 0.00 | 19,000 | 0 | 98,340 | 79.3 K to 98.3 K (+23.95 %) |
| Aug 22 2016 | SGEN | SEATTLE GENETICS I ... | DOBMEIER ERIC | Chief Operating Off ... | Buy | M | 15.46 | 245 | 3,788 | 79,340 | 79.1 K to 79.3 K (+0.31 %) |
| Aug 22 2016 | SGEN | SEATTLE GENETICS I ... | DOBMEIER ERIC | Chief Operating Off ... | Buy | M | 20.52 | 4,688 | 96,198 | 79,095 | 74.4 K to 79.1 K (+6.30 %) |
| Aug 22 2016 | SGEN | SEATTLE GENETICS I ... | DOBMEIER ERIC | Chief Operating Off ... | Sell | S | 42.02 | 8,548 | 359,226 | 74,407 | 83 K to 74.4 K (-10.30 %) |
| Aug 22 2016 | SGEN | SEATTLE GENETICS I ... | Cline Darren S | SVP, Commercial | Option Exercise | A | 39.15 | 27,780 | 1,087,587 | 27,780 | |
| Aug 22 2016 | SGEN | SEATTLE GENETICS I ... | Cline Darren S | SVP, Commercial | Option Exercise | A | 39.15 | 2,220 | 86,913 | 2,220 | |
| Aug 22 2016 | SGEN | SEATTLE GENETICS I ... | Cline Darren S | SVP, Commercial | Grant | A | 0.00 | 12,000 | 0 | 43,482 | 31.5 K to 43.5 K (+38.12 %) |
| Aug 22 2016 | SGEN | SEATTLE GENETICS I ... | Cline Darren S | SVP, Commercial | Sell | S | 42.02 | 2,231 | 93,757 | 31,482 | 33.7 K to 31.5 K (-6.62 %) |
| Aug 10 2016 | SGEN | SEATTLE GENETICS I ... | SIEGALL CLAY B | President and CEO | Option Exercise | M | 10.20 | 4,042 | 41,228 | 35,575 | |
| Aug 10 2016 | SGEN | SEATTLE GENETICS I ... | SIEGALL CLAY B | President and CEO | Option Exercise | M | 4.45 | 7,618 | 33,900 | 7,611 | |
| Aug 10 2016 | SGEN | SEATTLE GENETICS I ... | SIEGALL CLAY B | President and CEO | Sell | S | 47.33 | 7,618 | 360,568 | 556,115 | 563.7 K to 556.1 K (-1.35 %) |
| Aug 10 2016 | SGEN | SEATTLE GENETICS I ... | SIEGALL CLAY B | President and CEO | Buy | M | 4.45 | 7,618 | 33,900 | 563,733 | 556.1 K to 563.7 K (+1.37 %) |
| Aug 10 2016 | SGEN | SEATTLE GENETICS I ... | SIEGALL CLAY B | President and CEO | Sell | S | 46.92 | 4,042 | 189,644 | 556,115 | 560.2 K to 556.1 K (-0.72 %) |
| Aug 10 2016 | SGEN | SEATTLE GENETICS I ... | SIEGALL CLAY B | President and CEO | Buy | M | 10.20 | 4,042 | 41,228 | 560,157 | 556.1 K to 560.2 K (+0.73 %) |